FDA Accepts New Drug Application for Zidesamtinib

FLASCO is offering a FREE virtual program for ROS1+ lung cancer patients. This event will features leading lung cancer experts, advocacy groups, and support organizations coming together to provide clear, reliable information about the diagnosis and treatment landscape. Attendees will gain valuable insights from renowned specialists and have the chance to ask questions during the Q&A session. The goal is to empower patients with the knowledge and tools needed to navigate a cancer diagnosis...

A ROS1-positive lung cancer diagnosis can feel overwhelming. Beyond the physical challenges of treatment and symptom management, many...